Supriya Lifescience’s net profit rises 57% in Q1

10 Aug 2024 Evaluate

Supriya Lifescience has reported results for first quarter ended June 30, 2024 (Q1FY25). 

The company has reported 56.58% rise in its net profit of Rs 44.64 crore for Q1FY25 as compared to Rs 28.51 crore for the same quarter in the previous year. Total income of the company increased by 20.68% at Rs 162.85 crore for Q1FY25 as compared to Rs 134.94 crore for the corresponding quarter previous year.

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development.


Supriya Lifescience Share Price

734.80 -8.55 (-1.15%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×